Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03HYX
|
||||
| Former ID |
DAP001042
|
||||
| Drug Name |
Mometasone
|
||||
| Synonyms |
Elocom; Mometasona; Mometasonum; Mometasona [Spanish]; Mometasonum [Latin]; Asmanex (TN); Elocon (TN); Mometasone (INN); Nasonex (TN); Twisthaler (TN); (+)-Mometasone; (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 9,21-dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Skin allergies [ICD9: 995.3; ICD10:T78.4] | Approved | [536361] | ||
| Therapeutic Class |
Antiinflammatory Agents
|
||||
| Company |
Schering-Plough
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H28Cl2O4
|
||||
| Canonical SMILES |
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)<br />C
|
||||
| InChI |
1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
|
||||
| InChIKey |
QLIIKPVHVRXHRI-CXSFZGCWSA-N
|
||||
| CAS Number |
CAS 105102-22-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| ChEBI ID |
ChEBI:6970
|
||||
| SuperDrug ATC ID |
D07AC13; D07XC03; R01AD09; R03BA07
|
||||
| SuperDrug CAS ID |
cas=105102225
|
||||
| Target and Pathway | |||||
| Target(s) | Glucocorticoid receptor | Target Info | Agonist | [535655] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.